Human Papillomavirus and Cervical Screening: Misconceptions Undermine Adherence

Abstract

Purpose.

Prophylactic vaccination programs in conjunction with cervical screening can significantly reduce the incidence of cervical cancer worldwide. This study tested the hypothesis that human papillomavirus (HPV) vaccination can adversely affect adherence to cervical screening if the public develops the misconception that the HPV vaccination has removed the need for screening.

Design.

A postal survey using a stratified random sample was employed.

Participants.

Overall, 500 medical students and 500 nonmedical students of the Aristotle University of Thessaloniki were invited to participate. The response rate was 82%.

Measures.

A questionnaire was developed assessing demographic characteristics, adherence to cervical screening, and awareness and attitudes toward HPV.

Analysis.

Logistic regression was used to assess the impact of HPV awareness and attitudes towards HPV vaccination on adherence to Papanicolaou screening, controlling for place of origin and mother's screening behavior.

Results.

Students who believed that vaccination against HPV obviated the need for a Papanicolaou test were two times less likely to adhere to cervical screening (adjusted odds ratio, 1.89; 95% confidence interval, 1.37–2.57; p = .0004). The effect was stronger in the nonmedical subgroup (adjusted odds ratio, 3.05; 95% confidence interval, 1.85–5.160; p = .0003).

Conclusion.

Findings highlight that misconceptions can adversely affect preventive behaviors and reduce the probability of an early diagnosis of cervical cancer.

Keywords

Human Papillomavirus Adherence Cervical Screening Beliefs Prevention Research Manuscript format: applied research brief Research purpose: descriptive Study design: nonexperimental Outcome measure: behavioral Setting: school Health focus: medical self care Strategy: behavior change Target population age: youth Target population circumstances: Higher education Greece Greek

Get full access to this article

View all access options for this article.

References

Bosch

Lorincz

Munoz

Meijer

CJM

Shah

. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244–265.

Villa

Costa

Petta

Andrade

Paavonen

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase 11 efficacy trial. Lancet Oncol. 2005;6:271–278.

Harper

Franco

Wheeler

Moscicki

Romanowski

Efficacy of a bivalent L1 virus-like particle in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet. 2004;364:1757–1765.

Kohli

Hawes

Mamlin

Biondich

Johnson

. Estimating the long term impact of a prophylactic human papilloma virus (HPV) 16/18 vaccine on the burden of cervical disease in the UK (Poster P-200). Presented at the 23rd International Papilloma Conference and Clinical Workshop; 2006: London, United Kingdom.

Henry

. Kaiser Family Foundation. National Survey of Public Knowledge of HPV, the Human Papillomavirus. Washington, DC: Henry J. Kaiser Family Foundation; 2004.

Lambert

. College students knowledge of human papillomavirus and effectiveness of a brief intervention. J Am Board Fam Pract. 2001;14:178–183.

Brinton

. Ways that women may possibly reduce their risk of breast cancer. J Natl Cancer Inst. 1994;86:371–372.

Klug

Hetzer

Blettner

. Screening for breast and cervical cancer in a large German city: participation, motivation and knowledge of risk factors. Eur J Public Health. 2005;15:70–77.

Kelly

Leader

Mittermaier

Hornik

Cappella

. The HPV vaccine and the media: How has the topic been covered and what are the effects on knowledge about the virus and cervical cancer? Patient Educ Couns. 2009; 77:308–313.

10.

Martín-López

Hernández-Barrera

De Andres

Garrido

De Miguel

Breast and cervical cancer screening in Spain and predictors of adherence. Eur J Cancer Prev. In press.

11.

Kahn

Goodman

Huang

Slap

Emans

. Predictors of Papanicolaou smear return in a hospital-based adolescent and young adult clinic. Obstet Gynecol. 2003;101:490–499.

12.

Calloway

Jorgensen

Saraiya

Tsui

. Report from the CDC: a content analysis of news coverage of the HPV vaccine by US newspapers, January 2002 to June 2005. J Women's Health. 2006;15:803–809.

13.

Anhang

Stryker

Wright

Goldie

. News media coverage of human papillomavirus. Cancer. 2003;100:308–314.

14.

Hilton

Hunt

Langan

Bedford

Petticrew

. Newsprint media representations of the introduction of the HPV vaccination programme for cervical cancer prevention in the UK (2005–2008). Soc Sci Med. In press.